Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05177133
Title Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus) (AuspiCiOus)
Acronym AuspiCiOus
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Age Groups: senior | adult
Covered Countries NLD

Additional content available in CKB BOOST